Literature DB >> 25361872

Integrating palliative care into active cancer treatment.

Polly Mazanec, Maryjo Prince-Paul.   

Abstract

OBJECTIVES: To describe the evidence that palliative care, provided concurrently with disease-modifying treatment early in the course of a cancer diagnosis, can improve quality of life, length of survival, symptom burden, mood, and utilization of health services. DATA SOURCES: Current research, the National Consensus Guidelines for Quality Palliative Care, and the American Society of Clinical Oncology Provisional Opinion on Integrating Palliative Care into Standard Oncology Care.
CONCLUSION: Despite recommendations and evidence, only a subset of cancer centers and community-based oncology clinics currently implement palliative care into ambulatory disease-focused cancer care. IMPLICATIONS FOR NURSING PRACTICE: Oncology nurses can improve access by becoming knowledgeable about generalist palliative care and by advocating for local and national practice change.

Entities:  

Keywords:  Oncology nursing; Palliative care; Quality cancer care; Symptom management

Mesh:

Year:  2014        PMID: 25361872     DOI: 10.1016/j.soncn.2014.08.002

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  2 in total

1.  Characteristics and outcome of unplanned hospital admissions in patients with lung cancer: a longitudinal tertiary center study. Towards a strategy to reduce the burden.

Authors:  Kristof Cuppens; Christel Oyen; Aurélie Derweduwen; Anouck Ottevaere; Walter Sermeus; Johan Vansteenkiste
Journal:  Support Care Cancer       Date:  2016-01-27       Impact factor: 3.603

2.  Developing a complex intervention to support timely engagement with palliative care for patients with advanced cancer in primary and secondary care in the UK: a study protocol.

Authors:  Julia Hackett; Hilary Bekker; Michael I Bennett; Paul Carder; Jean Gallagher; Claire Henry; Suzanne Kite; Sally Taylor; Galina Velikova; Lucy Ziegler
Journal:  BMJ Open       Date:  2018-05-14       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.